Aminosalicylate Sodium

CHEMBL2096646 Phase 4 Approved Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
211.2 g/mol
LogP
Phase
4

The sodium salt of para-aminosalicylic acid (PAS), an older but still valuable second-line antibiotic for multidrug-resistant tuberculosis that works by blocking folate synthesis and iron metabolism in the tuberculosis bacteria. It is used as part of combination regimens when first-line drugs cannot be used due to drug resistance.

Molecular Weight

211.1500 g/mol

TPSA

88.40 Ų

Therapeutic Areas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Structure

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Nc1ccc(C(=O)[O-])c(O)c1.O.O.[Na+]

InChI

InChI=1S/C7H7NO3.Na.2H2O/c8-4-1-2-5(7(10)11)6(9)3-4;;;/h1-3,9H,8H2,(H,10,11);;2*1H2/q;+1;;/p-1

Molecular Formula

C7H10NNaO5

HBD / HBA

4 / 6

Rotatable Bonds

1

Heavy Atoms

14

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

The sodium salt of para-aminosalicylic acid (PAS), an older but still valuable second-line antibiotic for multidrug-resistant tuberculosis that works by blocking folate synthesis and iron metabolism in the tuberculosis bacteria. It is used as part of combination regimens when first-line drugs cannot be used due to drug resistance.

Yes, Aminosalicylate Sodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2096646. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 16211148. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.